基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 一抗 其他一抗 IRF9 antibody IRF9抗体
  • IRF9抗体
  • IRF9抗体
  • IRF9抗体

1/3

IRF9抗体

Rabbit Polyclonal IRF9 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-13

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
IRF9抗体
英文名称:
Rabbit Polyclonal IRF9 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 3518 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
IRF9

验证与应用

应用及物种
WB1/200-1/1000 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/1000-1/2000 Human,Mouse,Rat
   

产品详情

Aliasesp48; IRF-9; ISGF3; ISGF3G
WB Predicted band size44 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse
ImmunogenFusion protein of human IRF9
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane 1-2: Mouse panceas tissue, NIH/3T3 cells, Primary antibody: P07392(IRF9 Antibody) at dilution 1/380, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 1.5 minutes    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human tonsil tissue using P07392(IRF9 Antibody) at dilution 1/50. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P07392(IRF9 Antibody) at dilution 1/50. (Original magnification: ×200)    


           

参考文献

以下是关于IRF9抗体的3篇参考文献的简要概括(注:文献信息为示例性虚构,仅供参考):

1. **"IRF9 Mediates Antiviral Response by Regulating ISGF3 Complex Formation"**

- **作者**: Smith A, et al.

- **摘要**: 本研究利用IRF9特异性抗体,通过免疫共沉淀和Western blot技术,揭示了IRF9在干扰素信号通路中与STAT1/STAT2形成ISGF3复合体的关键作用,证实其在抗病毒基因激活中的必要性。

2. **"Tissue-Specific Expression of IRF9 in Autoimmune Disorders"**

- **作者**: Chen L, et al.

- **摘要**: 通过免疫组化和小鼠模型实验,作者使用IRF9抗体发现其在自身免疫疾病(如系统性红斑狼疮)患者的炎症组织中高表达,提示IRF9可能作为治疗靶点。

3. **"IRF9 Antibody-Based Detection of Transcriptional Regulation in Cancer"**

- **作者**: Gupta R, et al.

- **摘要**: 该研究采用IRF9抗体进行ChIP-seq分析,揭示了IRF9在肿瘤细胞中通过调控特定干扰素刺激基因(ISGs)影响肿瘤免疫逃逸的分子机制。

如需真实文献,建议通过PubMed或Google Scholar搜索关键词“IRF9 antibody”或“IRF9 function”,并筛选实验方法部分提及该抗体的研究。

       

背景信息

The IRF9 (Interferon Regulatory Factor 9) antibody is a key tool for studying the function of IRF9. a transcription factor critical in mediating interferon (IFN) signaling. IRF9 is a member of the interferon regulatory factor family and forms the ISGF3 (IFN-Stimulated Gene Factor 3) complex with phosphorylated STAT1 and STAT2 upon IFN-α/β stimulation. This complex translocates to the nucleus, binds IFN-stimulated response elements (ISREs), and activates the transcription of interferon-stimulated genes (ISGs) involved in antiviral defense, immune regulation, and cell proliferation. Dysregulation of IRF9 has been linked to autoimmune diseases, viral infections, and cancer, making it a target for therapeutic research.

IRF9 antibodies are widely used in molecular and cellular studies to detect IRF9 expression, localization, and interactions via techniques like Western blotting, immunofluorescence, and co-immunoprecipitation. They are essential for investigating IFN signaling dynamics, JAK-STAT pathway activity, and cellular responses to pathogens or cytokines. Commercially available IRF9 antibodies are typically generated in rabbits or mice using immunogenic peptides corresponding to conserved regions of human or murine IRF9. Validation includes specificity tests using knockout cell lines or siRNA-mediated knockdown. Researchers prioritize antibodies with high affinity, minimal cross-reactivity, and compatibility with their experimental models to ensure reliable data in studies on innate immunity, cancer biology, or inflammatory disorders.

       
IRF9抗体;IRF9;IRF9 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

IRF9抗体相关厂家报价

内容声明
拨打电话 立即询价